E’ indetta una procedura selettiva pubblica, per titoli e colloquio, per l'attribuzione di n. 1 assegno per lo svolgimento di attività di ricerca di categoria B) – Tipologia I della durata di 1 anno, rinnovabile, per il settore scientifico disciplinare MED/15 presso il Dipartimento di Biotecnologie Cellulari ed Ematologia dell’Università degli Studi di Roma “La Sapienza”.
Titolo della ricerca: Quality of Life: An Increasingly Important Feature of Myeloma Treatment
Progetto di ricerca:Multiple Myeloma (MM) patients have a substantially reduced Health related Quality of Life (HQOL) at diagnosis (dx) due to disease related symptoms like bone pain and fatigue. HQOL monitoring is becoming increasingly important, owing to improved survival and the impact of treatment-related toxicity. As a result, HQOL assessments are increasingly been used in clinical trials, but the literature regarding the relationship between HQOL and outcomes in MM is sparse. GIMEMA has designed the CLARITY study to investigate QOL in MM patients. For the framework of this project, we need a person dedicated to collect data from patients enrolled in the protocol, to insert data into the clinico-scientific database and to check the accuracy of the clinico-hematologic data in accordance with the experimental protocol standards.